Warning over surgery delays for thousands of patients
A leading surgeon was warned thousands of patients are not being prioritised for gallbladder surgery after pancreatitis – despite the risk of the condition returning that in some cases could kill them. (Source: HSJ)
Source: HSJ - November 20, 2017 Category: UK Health Source Type: news
Obesity and Pancreatitis Obesity and Pancreatitis
This review explores the mechanisms by which obesity contributes to and exacerbates acute pancreatitis, and examines potential therapies for this obesity-related disease.Current Opinion in Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 17, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Diseases of the pancreas and suicide mortality: a nationwide nested case-control study among patients with mental health disorders in Taiwan - Chen HM, Chen VC, Wang TN, Lu ML, Huang YC, Dewey ME, Lee JK, Tsai CP.
OBJECTIVE: Diseases of the pancreas, especially pancreatitis, have been implicated as possible risk factors for psychiatric illnesses, such as depression and anxiety disorder. This nested case-control study aimed to investigate the association between dise... (Source: SafetyLit)
Source: SafetyLit - October 14, 2017 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Enteral Nutrition Better for ICU Patients With Severe Pancreatitis Enteral Nutrition Better for ICU Patients With Severe Pancreatitis
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 28, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news
Pancreatic Enzyme Replacement in Chronic Pancreatitis Pancreatic Enzyme Replacement in Chronic Pancreatitis
Are there tangible benefits to pancreatic enzyme replacement therapy in chronic pancreatitis? For which patients might it be beneficial?Gut (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 14, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Can Next-Gen Obesity Balloon Pump Confidence in Apollo?
Apollo Endosurgery's Orbera365 weight-loss balloon works the same way as the original Orbera device, except it is designed to stay in the patient's stomach for 12 months, twice as long as the previous version.
Apollo Endosurgery said it has received CE Mark approval to sell its Orbera365 weight-loss system in Europe, doubling the amount of time the balloon stays inflated in the patient's stomach. The approval comes less than a month after FDA alerted doctors of patient deaths associated with obesity balloons made by Apollo and ReShape Medical.
The news deflated Apollo's stock (NASDAQ: APEN), as shares sold off nearly 26...
Source: MDDI - September 6, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news
Pancreas Bifidum With Acute Necrotizing Pancreatitis Pancreas Bifidum With Acute Necrotizing Pancreatitis
Learn about pancreas bifidum, a rare foregut anomaly, in this unusual case. Does having a bifid pancreas predispose to development of acute pancreatitis?Applied Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 4, 2017 Category: Consumer Health News Tags: Radiology Journal Article Source Type: news
Less-invasive Surgery Better for Very High-risk Patients With Necrotizing Pancreatitis Less-invasive Surgery Better for Very High-risk Patients With Necrotizing Pancreatitis
In the highest-risk patients with necrotizing pancreatitis, endoscopic and minimally invasive surgical necrosectomy are associated with lower mortality risk than open necrosectomy, according to data pooled from 15 cohorts in eight countries.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 16, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news
Deaths prompt renewed FDA warning on intragastric balloons
The FDA yesterday updated its warning of the risks associated with fluid-filled intragastric balloons after receiving new reports of the deaths of patients implanted with the devices.
Intragastric balloons, made by Apollo Endosurgery (NSDQ:APEN) and ReShape Medical, are used to treat obesity. Placed in the stomach orally in a minimally invasive endoscopic procedure, they’re designed to be filled with fluid and stay in the stomach for six months. Apollo’s Orbera intragastric balloon system is composed of a single balloon which is filled with saline, while ReShape’s integrated dual balloon system uses 2 balloo...
Source: Mass Device - August 11, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Regulatory/Compliance Wall Street Beat Weight loss Apollo Endosurgery ReShape Medical Source Type: news
Actemra Rheumatoid Arthritis Drug Tied to Significant Side Effects
Actemra, manufactured by Roche/Genentech, has been associated with heart attack, heart failure, stroke, pancreatitis, lung disease, gastrointestinal perforation, and more (Source: Disabled World)
Source: Disabled World - July 24, 2017 Category: Disability Tags: Pharmaceutical Source Type: news
Success with first 20 patients undergoing minimally invasive pancreatic transplant surgery
(Johns Hopkins Medicine) Surgeons at Johns Hopkins Medicine report that their first series of a minimally invasive procedure to treat chronic pancreas disease, known as severe pancreatitis, resulted in shorter hospital stays, less need for opioids and fewer complications, compared with standard surgical approaches. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 29, 2017 Category: International Medicine & Public Health Source Type: news
Hydrogel tech boosts success of transplanted insulin-producing cells
Credit: Christopher Moore, Georgia Tech
A hydrogel material embedded with a protein to improve blood vessel growth may boost the success rate of transplanting insulin-producing islet cells into patients with Type I diabetes, according to a preclinical study published in the journal Science Advances.
In the newly-published work, supported by the National Institutes of Health and the Juvenile Diabetes Research Foundation, the combination improved the survival rate of transplanted insulin-producing cells.
The technology could help people with diabetes or those who have had their pancreas removed due to severe pancreatitis....
Source: Mass Device - June 5, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Research & Development Georgia Institute of Technology Juvenile Diabetes Research Foundation (JDRF) National Institutes of Health (NIH) Source Type: news
Innovations in the management of chronic pancreatitis
(Medical University of South Carolina) Chronic pancreatitis is an increasingly common condition that is extremely painful and sometimes fatal. Strategies for managing chronic pancreatitis are changing rapidly, giving health practitioners new options. To keep practitioners abreast of these advancements, the Medical University of South Carolina organized the first international symposium on chronic pancreatitis in 2014 and will host another in 2018. A textbook that was published as a result of the first conference has just been released (April 2017). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 19, 2017 Category: International Medicine & Public Health Source Type: news
New Scoring System Tracks Disease Activity in Acute Pancreatitis New Scoring System Tracks Disease Activity in Acute Pancreatitis
A new scoring system uses five parameters to allow real-time assessment of clinical disease activity in patients with acute pancreatitis, according to a report from the Southern California Pancreas Study Group.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - May 19, 2017 Category: Surgery Tags: Gastroenterology News Source Type: news
Dr. Fred Gorelick designated the Binder Professor of Internal Medicine
Dr. Fred Sanford Gorelick, newly designated as the Henry J. and Joan W. Binder Professor of Internal Medicine, focuses his research on the mechanisms that initiate pancreatitis, a severe inflammatory disease that causes death in up to 5% of patients. (Source: Yale Science and Health News)
Source: Yale Science and Health News - May 18, 2017 Category: Universities & Medical Training Tags: Yale News Source Type: news
